Biotech · Private company · Mountain View, CA, US
NeuroPace
Track this companyFree. Adds NeuroPace to your Dealase workspace and tells you when its record changes.
Clinical trials94 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- RNS SystemPhase 2 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- NeuroPace RNS SystemFocal EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- Responsive stimulationEpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- Sham stimulationEpilepsyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- RNS System for Drug-Resistant Focal Epilepsy in Adolescents: A Real-World StudyENROLLING_BY_INVITATION · started Sep 14, 2026ClinicalTrials.gov NCT07823465 · fetched Nov 12, 2026
- RNS System LGS Feasibility StudyPHASE2 · ACTIVE_NOT_RECRUITING · started Oct 4, 2022ClinicalTrials.gov NCT05339126 · fetched Nov 12, 2026
- RNS System NAUTILUS StudyNA · COMPLETED · started Aug 9, 2022ClinicalTrials.gov NCT05147571 · fetched Nov 12, 2026
- RNS System RESPONSE StudyNA · TERMINATED · started Oct 27, 2021ClinicalTrials.gov NCT04839601 · fetched Nov 12, 2026
- Intracranial Neurophysiological Signatures of Fear and Anxiety in HumansNA · RECRUITING · started Oct 1, 2021ClinicalTrials.gov NCT05120635 · fetched Nov 12, 2026
- Responsive Neurostimulation For Loss Of Control EatingNA · ACTIVE_NOT_RECRUITING · started Apr 10, 2019ClinicalTrials.gov NCT03868670 · fetched Nov 12, 2026
- Navigation and Free Recall in Chronically Implanted HumansNA · COMPLETED · started May 1, 2016ClinicalTrials.gov NCT02781129 · fetched Nov 12, 2026
- RNS® System Epilepsy Post-Approval StudyCOMPLETED · started Jun 1, 2015ClinicalTrials.gov NCT02403843 · fetched Nov 12, 2026
- RNS® System LTT StudyPHASE4 · COMPLETED · started Apr 1, 2006ClinicalTrials.gov NCT00572195 · fetched Nov 12, 2026
NIH awards2
- Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut SyndromeFiscal year 2025 · $1.6MNIH RePORTER 5UH3NS109557-05 · fetched Nov 12, 2026
- Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut SyndromeFiscal year 2024 · $1.7MNIH RePORTER 5UH3NS109557-04 · fetched Nov 12, 2026